More from Renaissance Capital
Referenced Stocks

Hyperion Therapeutics prices IPO at $10.00, below the range

By Renaissance Capital,  July 26, 2012, 08:49:37 AM EDT

Hyperion Therapeutics, which is focused on the treatment of orphan diseases of the liver relating to the urea cycle, raised $50 million by offering 5 million shares at $10.00, below the range of $11.00 to $13.00. Because Hyperion had planned to offer only 4.2 million shares, there was no change in proceeds raised. Hyperion Therapeutics plans to list on the NASDAQ under the symbol HPTX. Leerink Swann and Cowen & Company acted as lead managers on the deal.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: News Headlines, IPOs

Referenced Stocks: HPTX



Latest News Video

Take Control Of Your Wealth
Take Control Of Your Wealth         
How to Avoid Getting Caught Pre-Defection
How to Avoid Getting Caught Pre-Def...
WSJ House of the Week: And the Winner Is…
WSJ House of the Week: And the Winn...
How to Invest When Interest Rates Rise
How to Invest When Interest Rates R...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.




Most Active by Volume:

Company Last Sale Change Net / %
PFE $ 29.40 0.24  0.82%
NOK $ 3.86 0.17  4.61%
S $ 7.32 0.10  1.39%
BAC $ 13.27 0.06  0.45%
GE $ 24.33 0.56  2.36%
MU $ 13.76 0.52  3.93%
SIRI $ 3.40 0.06  1.80%
MNKD $ 6.605 0.94  12.40%